• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性血小板减少性紫癜患者发生系统性红斑狼疮的风险:一项基于人群的队列研究。

Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study.

机构信息

Department of Rheumatology and Immunology, The Second Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.

Department of Medical Research, Chung Shan Medical University Hospital, Taichung City, Taiwan, Taiwan.

出版信息

Ann Rheum Dis. 2020 Jun;79(6):793-799. doi: 10.1136/annrheumdis-2020-217013. Epub 2020 Apr 2.

DOI:10.1136/annrheumdis-2020-217013
PMID:32241798
Abstract

BACKGROUND

Idiopathic thrombocytopenic purpura (ITP) may play a role in early-stage systemic lupus erythematosus (SLE). The incidence of SLE in patients with ITP and the potential relationship between them is still unclear. This study was performed to provide epidemiological evidence regarding the relationship between ITP and SLE occurrence.

METHODS

In this population-based retrospective cohort study, the risk of SLE was analysed in a cohort of patients newly diagnosed with ITP between 2000 and 2013. Controls were selected at a 1:2 ratio through propensity score matching (PSM) using the greedy algorithm. The Cox proportional hazard model was used to analyse the association between ITP and SLE incidence. There were four different Cox regression models, and the sensitivity analyses were implemented to evaluate the HR of SLE after exposure with ITP.

RESULTS

In the age-matched and sex-matched ITP and non-ITP cohort, the average follow-up time was about 80 months in this study. There were 34 (4.70%) and 27 (0.19%) incident cases of SLE in ITP and non-ITP group. The incidence rates were 62.0 (95% CI 44.3 to 86.8) and 2.10 (95% CI 1.44 to 3.06), respectively. The adjusted HR of incidental SLE in the ITP group was 25.1 (95% CI 13.7 to 46.0). The other risk factors for SLE were female sex and Sjogren's syndrome. After PSM, the incidence rate and Kaplan-Meir curves of SLE were consistent with the results for the age-matched and sex-matched population, the HR 17.4 (95% CI 5.28 to 57.4) was estimated by conditional Cox model.

CONCLUSION

This cohort study demonstrated that patients with ITP have a higher risk of SLE. Clinically, patients with ITP should be monitored for incidental lupus.

摘要

背景

特发性血小板减少性紫癜(ITP)可能在早期系统性红斑狼疮(SLE)中起作用。ITP 患者中 SLE 的发病率以及它们之间的潜在关系尚不清楚。本研究旨在为 ITP 与 SLE 发生之间的关系提供流行病学证据。

方法

在这项基于人群的回顾性队列研究中,分析了 2000 年至 2013 年间新诊断为 ITP 的患者队列中 SLE 的发病风险。通过使用贪婪算法进行倾向评分匹配(PSM),以 1:2 的比例选择对照。使用 Cox 比例风险模型分析 ITP 与 SLE 发生率之间的关联。有四个不同的 Cox 回归模型,进行了敏感性分析以评估暴露于 ITP 后 SLE 的 HR。

结果

在年龄匹配和性别匹配的 ITP 和非 ITP 队列中,本研究的平均随访时间约为 80 个月。ITP 和非 ITP 组分别有 34 例(4.70%)和 27 例(0.19%)SLE 发病病例。发病率分别为 62.0(95%CI 44.3 至 86.8)和 2.10(95%CI 1.44 至 3.06)。ITP 组意外 SLE 的调整后 HR 为 25.1(95%CI 13.7 至 46.0)。SLE 的其他危险因素为女性和干燥综合征。PSM 后,SLE 的发病率和 Kaplan-Meier 曲线与年龄匹配和性别匹配人群的结果一致,条件 Cox 模型估计 HR 为 17.4(95%CI 5.28 至 57.4)。

结论

本队列研究表明,ITP 患者发生 SLE 的风险更高。临床上,应监测 ITP 患者的狼疮意外发作。

相似文献

1
Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study.特发性血小板减少性紫癜患者发生系统性红斑狼疮的风险:一项基于人群的队列研究。
Ann Rheum Dis. 2020 Jun;79(6):793-799. doi: 10.1136/annrheumdis-2020-217013. Epub 2020 Apr 2.
2
Immune thrombocytopenia in systemic lupus erythematosus: Prevalence, risk factors, and a novel predictive model for risk assessment.系统性红斑狼疮中的免疫性血小板减少症:患病率、风险因素以及一种新型风险评估预测模型。
Med Clin (Barc). 2024 May 31;162(10):461-469. doi: 10.1016/j.medcli.2023.12.012. Epub 2024 Feb 20.
3
Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis.免疫性血小板减少性紫癜患者发生系统性红斑狼疮:系统荟萃分析。
Autoimmun Rev. 2023 Apr;22(4):103297. doi: 10.1016/j.autrev.2023.103297. Epub 2023 Feb 11.
4
Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: A retrospective study.自身免疫性疾病相关免疫性血小板减少症的临床特征:一项回顾性研究。
Medicine (Baltimore). 2016 Dec;95(50):e5565. doi: 10.1097/MD.0000000000005565.
5
Incidence and risk factors of systemic lupus erythematosus in patients with primary immune thrombocytopenia: a systematic review and meta-analysis.原发性免疫性血小板减少症患者发生系统性红斑狼疮的发病率及相关危险因素:系统评价和荟萃分析。
PeerJ. 2024 Apr 22;12:e17152. doi: 10.7717/peerj.17152. eCollection 2024.
6
Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.特定自身免疫性疾病成年患者发生静脉血栓栓塞的风险:一项针对美国商业保险参保人群队列的研究
Thromb Res. 2015 Jan;135(1):50-7. doi: 10.1016/j.thromres.2014.10.012. Epub 2014 Oct 22.
7
Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura.特发性血小板减少性紫癜患儿未来发生系统性红斑狼疮的危险因素。
Pediatr Blood Cancer. 2006 Oct 15;47(5 Suppl):657-9. doi: 10.1002/pbc.20970.
8
Hydroxychloroquine might reduce risk of incident endometriosis in patients with systemic lupus erythematosus: A retrospective population-based cohort study.羟氯喹可能降低红斑狼疮患者发生子宫内膜异位症的风险:一项基于人群的回顾性队列研究。
Lupus. 2021 Sep;30(10):1609-1616. doi: 10.1177/09612033211031009. Epub 2021 Jul 14.
9
Childhood-onset systemic lupus erythematosus and immune thrombocytopenia: Prevalence and risk factors.儿童发病系统性红斑狼疮和免疫性血小板减少症:患病率和危险因素。
Pediatr Blood Cancer. 2021 Aug;68(8):e29146. doi: 10.1002/pbc.29146. Epub 2021 May 27.
10
Risk of incident autoimmune diseases in patients with thymectomy.胸腺瘤患者发生自身免疫性疾病的风险。
Ann Clin Transl Neurol. 2020 Jul;7(7):1072-1082. doi: 10.1002/acn3.51055. Epub 2020 Jun 1.

引用本文的文献

1
Primary versus Secondary Immune Thrombocytopenia (ITP): A Meeting Report from the 2023 McMaster ITP Summit.原发性与继发性免疫性血小板减少症(ITP):2023年麦克马斯特ITP峰会会议报告
Thromb Haemost. 2025 Sep;125(9):923-932. doi: 10.1055/a-2508-1112. Epub 2024 Dec 24.
2
The Multiple Faces of Systemic Lupus Erythematosus: Pearls and Pitfalls for Diagnosis.系统性红斑狼疮的多面性:诊断要点与陷阱
Mediterr J Rheumatol. 2024 Jun 30;35(Suppl 2):319-327. doi: 10.31138/mjr.130124.ppa. eCollection 2024 Jun.
3
Incidence and risk factors of systemic lupus erythematosus in patients with primary immune thrombocytopenia: a systematic review and meta-analysis.
原发性免疫性血小板减少症患者发生系统性红斑狼疮的发病率及相关危险因素:系统评价和荟萃分析。
PeerJ. 2024 Apr 22;12:e17152. doi: 10.7717/peerj.17152. eCollection 2024.
4
New-onset Systemic Lupus Erythematosus Manifestation Following COVID-19: A Case Report and Literature Review.COVID-19 后新发系统性红斑狼疮表现:病例报告及文献复习。
Intern Med. 2024 May 15;63(10):1491-1498. doi: 10.2169/internalmedicine.3211-23. Epub 2024 Feb 19.
5
Classifying systemic lupus erythematosus using laboratory items alone: a preliminary study.单纯使用实验室指标对系统性红斑狼疮进行分类:一项初步研究。
Clin Rheumatol. 2024 Mar;43(3):1037-1043. doi: 10.1007/s10067-024-06893-9. Epub 2024 Feb 12.
6
Severe Thrombocytopenia as the Main Manifestation of Childhood-Onset Systemic Lupus Erythematosus.严重血小板减少症作为儿童期系统性红斑狼疮的主要表现
Mediterr J Rheumatol. 2022 Dec 31;33(4):459-464. doi: 10.31138/mjr.33.4.459. eCollection 2022 Dec.
7
Risk of gout attack not increased in patients with thalassemia: a population-based cohort study.地中海贫血患者痛风发作风险并未增加:一项基于人群的队列研究。
Sci Rep. 2023 Feb 16;13(1):2756. doi: 10.1038/s41598-023-29709-3.
8
Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis.免疫性血小板减少性紫癜患者发生系统性红斑狼疮:系统荟萃分析。
Autoimmun Rev. 2023 Apr;22(4):103297. doi: 10.1016/j.autrev.2023.103297. Epub 2023 Feb 11.
9
Patterns of Outpatient Phecodes Predating the Diagnosis of Systemic Lupus Erythematosus in Taiwanese Women.台湾女性系统性红斑狼疮诊断前的门诊疾病编码模式
J Clin Med. 2022 Sep 14;11(18):5406. doi: 10.3390/jcm11185406.
10
Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia.免疫性血小板减少症患者发生系统性红斑狼疮的预后因素。
Arthritis Res Ther. 2022 Sep 6;24(1):213. doi: 10.1186/s13075-022-02901-y.